Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc.
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) held its annual general and special meeting on March 24, 2025, where shareholders approved key resolutions. The most significant outcome was the approval of a company name change to Organigram Global Inc., receiving 95.778% affirmative votes. The name change is pending regulatory approvals, including TSX conditional approval.
All ten board nominees listed in the February 12, 2025 management circular were elected. Following the meeting, the company announced updates to its committee compositions, with new arrangements for the Investment Committee and the Governance, Nominating and Sustainability Committee, while the Audit and Compensation Committees remained unchanged.
Shareholders also approved the appointment of PKF O'Connor Davies LLP as the company's auditor with 95.148% of votes in favor, authorizing directors to determine their remuneration.
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) ha tenuto la sua assemblea generale e speciale annuale il 24 marzo 2025, dove gli azionisti hanno approvato importanti risoluzioni. L'esito più significativo è stata l'approvazione del cambio di nome dell'azienda in Organigram Global Inc., ricevendo il 95,778% dei voti favorevoli. Il cambio di nome è in attesa di approvazioni regolatorie, inclusa l'approvazione condizionale della TSX.
Tutti e dieci i candidati al consiglio elencati nel circolare di gestione del 12 febbraio 2025 sono stati eletti. Dopo l'assemblea, l'azienda ha annunciato aggiornamenti alle composizioni dei suoi comitati, con nuove disposizioni per il Comitato per gli Investimenti e il Comitato per la Governance, Nominazioni e Sostenibilità, mentre i Comitati per la Revisione e per la Retribuzione sono rimasti invariati.
Gli azionisti hanno anche approvato la nomina di PKF O'Connor Davies LLP come revisore dell'azienda con il 95,148% dei voti favorevoli, autorizzando i direttori a determinare la loro retribuzione.
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) celebró su reunión general y especial anual el 24 de marzo de 2025, donde los accionistas aprobaron resoluciones clave. El resultado más significativo fue la aprobación de un cambio de nombre de la empresa a Organigram Global Inc., recibiendo el 95,778% de votos a favor. El cambio de nombre está pendiente de aprobaciones regulatorias, incluida la aprobación condicional de la TSX.
Los diez candidatos al consejo enumerados en el circular de gestión del 12 de febrero de 2025 fueron elegidos. Tras la reunión, la empresa anunció actualizaciones a las composiciones de sus comités, con nuevos arreglos para el Comité de Inversiones y el Comité de Gobernanza, Nominaciones y Sostenibilidad, mientras que los Comités de Auditoría y Compensación permanecieron sin cambios.
Los accionistas también aprobaron la designación de PKF O'Connor Davies LLP como auditor de la empresa con el 95,148% de votos a favor, autorizando a los directores a determinar su remuneración.
Organigram Holdings (TSX: OGI) (NASDAQ: OGI)는 2025년 3월 24일 연례 총회 및 특별 회의를 개최하였으며, 주주들은 주요 결의안을 승인하였습니다. 가장 중요한 결과는 회사 이름을 Organigram Global Inc.로 변경하는 것이 승인되었으며, 95.778%의 찬성 투표를 받았습니다. 이름 변경은 TSX의 조건부 승인을 포함한 규제 승인을 기다리고 있습니다.
2025년 2월 12일 관리 서한에 나열된 10명의 이사 후보 모두가 선출되었습니다. 회의 후, 회사는 투자 위원회 및 거버넌스, 추천 및 지속 가능성 위원회에 대한 새로운 구성 업데이트를 발표했으며, 감사 및 보상 위원회는 변경되지 않았습니다.
주주들은 또한 PKF O'Connor Davies LLP를 회사의 감사인으로 임명하는 것을 95.148%의 찬성으로 승인하였으며, 이사들이 그들의 보수를 결정할 수 있도록 권한을 부여하였습니다.
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) a tenu son assemblée générale et spéciale annuelle le 24 mars 2025, où les actionnaires ont approuvé des résolutions clés. Le résultat le plus significatif a été l'approbation d'un changement de nom de l'entreprise en Organigram Global Inc., recevant 95,778% de votes favorables. Le changement de nom est en attente d'approbations réglementaires, y compris l'approbation conditionnelle de la TSX.
Les dix candidats au conseil énumérés dans le circulaire de gestion du 12 février 2025 ont été élus. Après la réunion, l'entreprise a annoncé des mises à jour concernant la composition de ses comités, avec de nouveaux arrangements pour le Comité des investissements et le Comité de gouvernance, de nomination et de durabilité, tandis que les Comités d'audit et de rémunération sont restés inchangés.
Les actionnaires ont également approuvé la nomination de PKF O'Connor Davies LLP en tant qu'auditeur de l'entreprise avec 95,148% des voix en faveur, autorisant les directeurs à déterminer leur rémunération.
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) hielt am 24. März 2025 seine jährliche Haupt- und Sonderversammlung ab, bei der die Aktionäre wichtige Beschlüsse genehmigten. Das bedeutendste Ergebnis war die Genehmigung einer Namensänderung des Unternehmens in Organigram Global Inc., die 95,778% der Stimmen erhielt. Die Namensänderung steht noch unter dem Vorbehalt regulatorischer Genehmigungen, einschließlich der bedingten Genehmigung durch die TSX.
Alle zehn im Managementrundschreiben vom 12. Februar 2025 aufgeführten Vorstandsnominierten wurden gewählt. Nach der Versammlung gab das Unternehmen Aktualisierungen zu den Zusammensetzungen seiner Ausschüsse bekannt, mit neuen Regelungen für den Investitionsausschuss und den Governance-, Nominierungs- und Nachhaltigkeitsausschuss, während der Prüfungs- und Vergütungsausschuss unverändert blieb.
Die Aktionäre genehmigten auch die Ernennung von PKF O'Connor Davies LLP als Wirtschaftsprüfer des Unternehmens mit 95,148% der Stimmen dafür und ermächtigten die Direktoren, ihre Vergütung festzulegen.
- None.
- None.
Shareholder Approval of the Name Change and Articles of Amendment
At the Meeting, a special resolution approving an amendment to the articles of the Company to change the name of the Company to “Organigram Global Inc.” (the “Name Change”), was approved by the affirmative vote of
The Name Change remains subject to regulatory approvals, including the approval of the TSX. The TSX has conditionally approved the Name Change subject to the Company fulfilling all requirements of the TSX.
Election of Directors
Each of the ten nominees listed in the Company’s management information circular dated February 12, 2025 (the “Circular”) provided in connection with the Meeting were elected as directors of the Company. The Company received proxies and virtual votes at the Meeting as set out below:
Nominee |
# Votes For |
% of Votes
|
# Votes
|
% of Votes
|
Peter Amirault |
46,410,326 |
|
1,792,595 |
|
Dexter John |
47,407,753 |
|
795,167 |
|
Stephen Smith |
47,430,497 |
|
772,423 |
|
Geoffrey Machum |
47,443,066 |
|
759,854 |
|
Sherry Porter |
47,367,514 |
|
835,406 |
|
Marni Wieshofer |
47,431,047 |
|
771,873 |
|
Simon Ashton |
47,421,514 |
|
781,407 |
|
Karina Gehring |
47,442,873 |
|
760,048 |
|
Craig Harris |
47,420,091 |
|
782,829 |
|
Beena Goldenberg |
39,191,600 |
|
9,001,320 |
|
The biographies of the Company’s directors are set out in the Circular, which is available under the Company’s profile on SEDAR+ at www.sedarplus.ca. and on EDGAR at www.sec.gov.
Committee Composition
Following the Meeting, the Board has reviewed and approved the composition of its Committees. The Investment Committee now consists of Dexter John (Chair), Stephen Smith, Marni Wieshofer, Simon Ashton and Craig Harris. The Governance, Nominating and Sustainability Committee now consists of Geoff Machum (Chair), Sherry Porter, Dexter John and Craig Harris. The Audit Committee remains unchanged consisting of Stephen Smith (Chair), Dexter John, Marni Wieshofer and Simon Ashton and the Compensation Committee remains unchanged consisting of Sherry Porter (Chair), Geoff Machum and Karina Gehring.
Appointment of Auditor
Further, an ordinary resolution approving the appointment of PKF O'Connor Davies LLP as the Company’s auditor until the next annual meeting of the shareholders of the Company or until its successor is duly appointed and authorizing the directors of the Company to fix its remuneration was approved by the affirmative vote of
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in
Organigram is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include receipt of all required regulatory approvals including final approval from the TSX, and factors and risks as disclosed in the Circular, and the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Such assumptions include, without limitation, that all conditions for approval of the name change will be satisfied. The forward-looking information included in this news release is provided as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250324943457/en/
For Investor Relations enquiries:
Max Schwartz, Director of Investor Relations
investors@organigram.ca
For Media enquiries:
Megan McCrae, Senior Vice President – Global Brands and Corporate Affairs
megan.mccrae@organigram.ca
Source: Organigram Holdings Inc.
FAQ
What was the voting result for Organigram's (OGI) name change to Organigram Global Inc.?
When did Organigram (OGI) hold its annual and special meeting in 2025?
Who was appointed as Organigram's (OGI) auditor at the 2025 annual meeting?
What changes were made to Organigram's (OGI) committee structure after the 2025 annual meeting?
